149 related articles for article (PubMed ID: 15062056)
1. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
[TBL] [Abstract][Full Text] [Related]
2. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
3. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma.
Wang S; Ding YB; Chen GY; Xia JG; Wu ZY
World J Gastroenterol; 2004 Jun; 10(12):1815-8. PubMed ID: 15188513
[TBL] [Abstract][Full Text] [Related]
5. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y
Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
8. Progressive loss of Syk and abnormal proliferation in breast cancer cells.
Moroni M; Soldatenkov V; Zhang L; Zhang Y; Stoica G; Gehan E; Rashidi B; Singh B; Ozdemirli M; Mueller SC
Cancer Res; 2004 Oct; 64(20):7346-54. PubMed ID: 15492255
[TBL] [Abstract][Full Text] [Related]
9. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
Inayat U; Kayani MA; Faryal R
Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
[TBL] [Abstract][Full Text] [Related]
10. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
11. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
12. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.
Coopman PJ; Do MT; Barth M; Bowden ET; Hayes AJ; Basyuk E; Blancato JK; Vezza PR; McLeskey SW; Mangeat PH; Mueller SC
Nature; 2000 Aug; 406(6797):742-7. PubMed ID: 10963601
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of HRad17 mRNA in human breast cancer: correlation with lymph node metastasis.
Kataoka A; Sadanaga N; Mimori K; Ueo H; Barnard GF; Sugimachi K; Auclair D; Chen LB; Mori M
Clin Cancer Res; 2001 Sep; 7(9):2815-20. PubMed ID: 11555598
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of SYK expression by inhibition of DNA methylation suppresses breast cancer cell invasiveness.
Yuan Y; Liu H; Sahin A; Dai JL
Int J Cancer; 2005 Feb; 113(4):654-9. PubMed ID: 15455373
[TBL] [Abstract][Full Text] [Related]
15. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
Dong SW; Zhang P; Zhong RR; Liu Q
Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
[TBL] [Abstract][Full Text] [Related]
16. Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival.
Dejmek J; Leandersson K; Manjer J; Bjartell A; Emdin SO; Vogel WF; Landberg G; Andersson T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):520-8. PubMed ID: 15701836
[TBL] [Abstract][Full Text] [Related]
17. Syk: a new player in the field of breast cancer.
Stewart ZA; Pietenpol JA
Breast Cancer Res; 2001; 3(1):5-7. PubMed ID: 11250739
[TBL] [Abstract][Full Text] [Related]
18. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
20. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]